J. Vamecq et al., ANTICONVULSANT ACTIVITY AND INTERACTIONS WITH NEURONAL VOLTAGE-DEPENDENT SODIUM-CHANNEL OF ANALOGS OF AMELTOLIDE, Journal of medicinal chemistry, 41(18), 1998, pp. 3307-3313
Fifteen compounds related to ameltolide (LY 201116) were studied for (
i) anticonvulsant potential in the maximal electroshock-induced seizur
es (MES) and the subcutaneous pentylenetetrazol (sc Ptz) tests in mice
and rats and (ii) interactions with neuronal voltage-dependent sodium
channels. Compounds were chosen ranging in anticonvulsant activity in
mice from very active to inactive. The active compounds were defined
as those protecting 50% of the animals at doses between 10 and 50 mu m
ol/kg and inactive compounds as those protecting 50% of the animals at
doses greater than 1 mmol/kg. The series studied included three N-(2,
6-dimethylphenyl)benzamides (compounds 1, 2 (ameltolide), and 3), thre
e N-(2,2,6,6-tetramethyl)piperidinyl-4-benzamides (compounds 4, 5, 6),
one phenylthiourea (compound 7), five N-(2,6-dimethylphenyl)phthalimi
des (compounds 8, 9, 10, 13, and 14), two N-phenylphthalimide derivati
ves (compounds 11 and 12), and one N-(2,2,6,6-tetramethyl)piperidinyl-
4-phtalimide (compound 15). Phenytoin (PHT) was employed as the refere
nce prototype antiepileptic drug. After inital screening in mice, comp
ounds 1, 2, 3, 5, 8, 9, 10, 13, and 14 were selected for further testi
ng in rats. Anticonvulsant ED(50)s (effective doses in at least 50% of
animals tested) of compounds in the MES test were determined in rats
dosed orally and amounted to 52 (1), 135 (2), 284 (3), 31 (8), 131 (9)
, 25 (10), 369 (13), 354 (14), and 121 (PHT) mu mol/kg, compound 5 pre
senting with an ED50 value higher than 650 mu mol/kg. In our hands, th
e apparent IC(50)s (inhibitory concentrations 50) of compounds toward
binding to rat brain synaptosomes of [H-3]batrachotoxinin-A-20 alpha-b
enzoate were 0.25 (1), 0.97 (2), 0.35 (3), 25.8 (5), 161.3 (8), 183.5
(9), 0.11 (10), 1.86 (13), 47.8 (14), and 0.86 (PHT) mu M. The relatio
nship between the activity in the MES test and the capacity to interac
t in vitro with neuronal voltage-dependent sodium channels and the fac
t that the IC50 values obtained in the in vitro test are close to the
brain concentrations at which anticonvulsant activities are reported t
o occur for ameltolide strongly suggest that the anticonvulsant proper
ties of most compounds tested could be a direct result of their intera
ction with the neuronal voltage-dependent sodium channel.